Dsip Coa: Certificate of Analysis & Analytical Standards

Direct Answer: What is a DSIP COA?

A DSIP COA (Certificate of Analysis) is an official quality verification document produced by an independent, ISO 17025-accredited analytical laboratory confirming the identity, purity profile, and safety metrics of Delta Sleep-Inducing Peptide. It documents exact chemical parameters, including mass identity verification via Mass Spectrometry (MS), net peptide purity via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), and bacterial endotoxin levels via Limulus Amebocyte Lysate (LAL) testing.

For laboratory researchers evaluating peptide reagents, a valid DSIP COA ensures that the compound matches its theoretical molecular weight (848.81 g/mol) and contains zero unauthorized fillers, heavy metals, or residual synthesis reagents that could compromise experimental reproducibility in cell culture or animal models.

Molecular Identity and Chemical Structure of DSIP

Delta Sleep-Inducing Peptide (DSIP) is a well-characterized nonapeptide with the primary amino acid sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Discovered in 1977 from the hemodialysate of rabbits subjected to electrical stimulation of the thalamus, DSIP has remained a subject of extensive neuroendocrine study due to its distinct regulatory properties across mammalian physiological systems.

The molecular mass of DSIP is precisely calculated at 848.81 Da. Its chemical structure features an N-terminal tryptophan residue and a C-terminal glutamic acid residue, rendering the molecule amphipathic with distinct hydrophobic and hydrophilic domains. In physiological and laboratory buffer systems, the peptide exhibits high solubility, though its aromatic tryptophan residue requires careful protection from photo-oxidation during handling and storage.

Researchers analyzing peptide stability across structural classes frequently cross-reference data from our comprehensive DSIP reference guide to contextualize structural characterization metrics alongside our full catalog of research peptides.

Preclinical Mechanisms: Delta-Wave Induction and Stress-Axis Modulation

Preclinical studies indicate that DSIP acts primarily as a central neuromodulator rather than a direct hypnotic agent. Research in rodent and non-human primate models demonstrates that administration of DSIP enhances slow-wave electroencephalogram (EEG) activity, specifically increasing power in the delta frequency band (0.5–4 Hz) associated with deep phase-3 non-REM rest.

In addition to sleep architecture regulation, preclinical literature shows that DSIP interacts with the hypothalamic-pituitary-adrenal (HPA) axis. In vitro and in vivo models suggest that the peptide modulates corticotropin-releasing factor (CRF) and adrenocorticotropic hormone (ACTH) secretion, effectively attenuating systemic baseline glucocorticoid elevations during acute physiological stress protocols.

Furthermore, animal models evaluating metabolic recovery during physiological strain suggest DSIP plays a role in oxidative stress attenuation and mitochondrial membrane protection. In vitro assays demonstrate its capacity to reduce lipid peroxidation markers in neuronal cellular isolates exposed to hypoxic conditions.

Analytical Purity Verification: RP-HPLC and Mass Spectrometry

To establish reagent integrity, every batch of DSIP 5mg undergoes dual-stage analytical testing combining Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS). RP-HPLC separates chemical species based on hydrophobic interactions with a stationary phase (typically C18 silica), allowing for exact quantification of peptide purity relative to synthesis side-products or truncated sequences.

A compliant DSIP COA must present an RP-HPLC chromatogram displaying a sharp, single main peak corresponding to the intact nonapeptide, with an integrated peak area representing ≥98.0% total purity. Secondary peaks, representing minor chemical impurities or deamidation artifacts, must remain strictly below predefined laboratory thresholds (<0.5% per individual peak).

Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) is conducted concurrently to confirm identity. The observed mass peak must match the theoretical protonated adduct ([M+H]+ at ~849.8 m/z) within an strict analytical tolerance of ±0.5 Da, ruling out incorrect amino acid sequences or structural isomer failures.

Endotoxin Testing and Bioburden Standards for In Vitro Research

Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—pose a significant risk of experimental contamination. Even trace amounts of endotoxin in peptide reagents can trigger inflammatory signaling cascades, activation of Toll-like receptor 4 (TLR4), and downstream cytokine release in cell culture models, invalidating baseline metabolic data.

PX1 Research mandates rigorous Chromogenic LAL (Limulus Amebocyte Lysate) testing for every lot of DSIP. A valid COA explicitly states the measured endotoxin content in Endotoxin Units per milligram (EU/mg). Our internal research specifications dictate an endotoxin threshold of <0.01 EU/mg, exceeding standard commercial research requirements and ensuring suitability for sensitive cell-line assays and microinjection protocols.

Understanding bioburden parameters is essential for high-throughput screening applications. Researchers seeking deeper technical specifications regarding raw material testing can browse our PX1 peptide intelligence hub for white papers detailing analytical purity methods.

How to Read and Verify a DSIP Certificate of Analysis

Interpreting a DSIP COA requires a systematic review of critical data fields to confirm lot authenticity and quality parameters before unsealing vials in the laboratory. Key sections that must be verified include:

1. Product Identifier & Lot Number: The lot number listed on the vial label must match the COA header exactly to guarantee lot traceability. 2. Chemical Formula & CAS Number: DSIP is designated by CAS number 62568-57-4 and molecular formula C35H48N10O15. 3. Physical Appearance: Verified as a white to off-white lyophilized powder. 4. RP-HPLC Chromatogram: Shows retention time, solvent gradient conditions (e.g., Water/Acetonitrile with 0.1% TFA), and total integrated purity percentage. 5. Mass Spectrum: Graphic representation confirming observed molecular ion mass against theoretical values. 6. Endotoxin & Water Content: LAL results and residual moisture percentage (typically Karl Fischer titration, target <5%).

Laboratory personnel purchasing through wholesale lab accounts receive direct digital access to downloadable, high-resolution PDF COAs corresponding directly to their assigned shipment lots.

Comparative Analysis: DSIP alongside Epitalon and Selank in Regulatory Research

When designing preclinical models investigating neuroendocrine homeostasis, circadian rhythm control, and stress adaptation, researchers frequently evaluate DSIP in tandem with other regulatory peptides. Understanding structural and functional distinctions aids in selecting appropriate control or synergistic research agents.

While DSIP targets delta-wave sleep architecture and HPA-axis corticotropin dynamics, compounds like Epitalon operate primarily through pineal gland regulation, telomerase activation, and melatonin synthesis pathways. Conversely, Selank—a synthetic derivative of the human immunomodulatory peptide tuftsin—acts mainly on GABAergic neurotransmission and BDNF expression to modulate central anxiety responses without inducing sedation. Similarly, Semax provides neuroprotective and cognitive research utility via ACTH-derived melanocortin signaling.

Evaluating these compounds side-by-side in vitro allows laboratories to isolate specific signal transduction pathways, differentiating circadian/sleep induction mechanisms (DSIP) from genomic/longevity markers (Epitalon) and monoaminergic/neurotrophic pathways (Selank).

Laboratory Reconstitution and Handling Protocols

Proper reconstitution technique is critical to maintaining peptide integrity and preventing mechanical degradation or bacterial contamination during laboratory preparation. Lyophilized DSIP should be allowed to equilibrate to room temperature inside a laminar flow hood before reconstitution.

For standard analytical assays, reconstitute lyophilized DSIP using sterile Bacteriostatic Water (0.9% Benzyl Alcohol) or sterile 0.9% Sodium Chloride injection solution. Reconstitution should be performed by gently running the solvent down the inner glass wall of the vial. Do not shake or violently agitate the solution; instead, gently swirl the vial until complete dissolution occurs.

If hydrophobic aggregation is observed at high concentrations, a mild buffering solution such as phosphate-buffered saline (PBS, pH 7.4) may be utilized. Aliquot the reconstituted solution into sterile, low-protein-binding microcentrifuge tubes to prevent repeated freeze-thaw cycles, which degrade peptide bonds over time.

US Manufacturing, Lot Traceability, and Quality Assurance at PX1 Research

All research peptides supplied by PX1 Research are synthesized in state-of-the-art facilities located within the United States, fully compliant with cGMP manufacturing frameworks and subject to rigorous ISO 17025 third-party laboratory audits.

Unlike vendors relying on unverified international bulk re-sellers, PX1 Research enforces absolute chain-of-custody controls. Every batch of DSIP undergoes independent verification after lyophilization, ensuring zero batch-to-batch variability and complete chemical consistency across extended multi-phase research initiatives.

Orders placed with PX1 Research ship directly from our centralized distribution hubs in California and Arizona. Orders confirmed Monday through Friday before 12:00 PM PST are processed with same-day shipping, ensuring ultra-cold or temperature-controlled transit schedules are fully maintained to preserve compound integrity upon delivery.

Storage Parameters and Retesting Intervals

Lyophilized DSIP powder exhibits high thermodynamic stability when stored under appropriate ambient conditions. For long-term storage (12–24 months), lyophilized vials must be preserved at -20°C to -80°C, sealed away from moisture and direct light exposure.

Once reconstituted into aqueous solution, the peptide is susceptible to peptide bond hydrolysis and tryptophan oxidation. Reconstituted aliquots must be stored at 2°C to 8°C for short-term use (up to 7–14 days depending on bacteriostatic agent) or stored frozen at -80°C for extended experimental protocols (up to 3 months). Avoid frost-free freezers due to temperature fluctuations during automatic defrost cycles.

PX1 Research assigns a standard 24-month retest date to all lyophilized DSIP batches from the date of initial synthesis validation. Analytical re-testing guarantees that potency and purity parameters listed on the original COA remain accurate throughout the recommended shelf-life window.